{
    "diseases": {
      "oncology": {
  "primaryClassificationFields": {
    "cancerType": ["Lung", "Breast", "Colorectal", "Melanoma", "Other"],
    "histologicalClassification": [
      "Adenocarcinoma",
      "Squamous cell carcinoma",
      "Small cell carcinoma",
      "Large cell carcinoma",
      "Mixed types"
    ],
    "stages": ["Stage I", "Stage II", "Stage III", "Stage IV"],
    "molecularGenetics": {
      "driverMutations": ["EGFR", "ALK", "ROS1", "KRAS", "BRAF", "HER2"],
      "biomarkers": ["PD-L1", "TMB", "MSI-High", "HRD"]
    },
    "priorLinesOfTherapy": [
      "Treatment naive",
      "First-line",
      "Second-line",
      "Third-line or greater",
      "Maintenance therapy"
    ]
  },
  "primaryClassificationFieldOrder": [
    "cancerType",
    "histologicalClassification",
    "stages",
    "molecularGenetics",
    "priorLinesOfTherapy"
  ],
  "primaryEndpoints": [
    "Overall Survival (OS)",
    "Progression-Free Survival (PFS)",
    "Disease-Free Survival (DFS)",
    "Objective Response Rate (ORR)",
    "Complete Response Rate (CR)",
    "Duration of Response (DoR)",
    "Time to Progression (TTP)",
    "Safety/Tolerability"
  ],
 "studyDesignCriteria": {
    "trialPhases": [
        "Phase 1",
        "Phase 1/2",
        "Phase 2",
        "Phase 2/3",
        "Phase 3",
        "Phase 4",
        "Pilot Study"
    ],
    "randomization": [
        "Randomized",
        "Non-randomized"
    ],
    "blinding": [
        "Blinded",
        "Open label",
        "Double-blind",
        "Single-blind"
    ],
    "trialType": [
        "Basket trial",
        "Umbrella trial",
        "Platform trial",
        "Parallel group",
        "Crossover study"
    ]
},
  "specialPopulationCriteria": [
    "Stable brain metastases allowed",
    "Active brain metastases allowed",
    "No brain metastases allowed",
    "Brain metastases required",
    "Adequate bone marrow function",
    "Adequate liver function",
    "Adequate renal function",
    "Adequate cardiac function"
  ]
},

      "hematology": {
        "primaryClassificationFields": {
          "diseaseCategory": ["Leukemia", "Lymphoma", "Multiple Myeloma", "Myelodysplastic Syndromes"],
          "molecularGenetics": {
            "cytogenetics": ["Normal", "Complex", "Specific abnormalities (e.g., t(9;22), FLT3)"],
            "mutations": ["NPM1", "FLT3-ITD", "IDH1/2", "BCR-ABL"]
          },
          "riskClassification": ["Low risk", "Intermediate risk", "High risk", "Very high risk"],
          "priorTreatments": [
            "Treatment naive",
            "Prior chemotherapy",
            "Prior targeted therapy",
            "Prior transplant",
            "CAR-T therapy"
          ]
        },
        "primaryEndpoints": [
          "Complete Response (CR)",
          "Overall Response Rate (ORR)",
          "Minimal Residual Disease (MRD)",
          "Event-free Survival (EFS)",
          "Overall Survival (OS)",
          "Transfusion independence"
        ],
        "studyDesignCriteria": [
          "Phase 1",
          "Phase 2",
          "Phase 3",
          "Basket trial",
          "Umbrella trial"
        ],
        "specialPopulationCriteria": [
          "High-risk cytogenetics",
          "Adequate organ function",
          "Post-transplant settings",
          "Pediatric patients"
        ]
      },
      "cardiovascular": {
        "primaryClassificationFields": {
          "diseaseCategory": ["CAD", "PAD", "Heart Failure", "Arrhythmias", "Structural Heart Disease"],
          "nyhaClass": ["Class I", "Class II", "Class III", "Class IV"],
          "riskFactors": ["Hypertension", "Diabetes", "Dyslipidemia", "Smoking"],
          "biomarkers": ["NT-proBNP", "Troponin", "CRP", "Lipid profile"]
        },
        "primaryEndpoints": [
          "MACE",
          "CV Death",
          "MI",
          "Stroke",
          "Hospitalization",
          "Exercise capacity",
          "Quality of life measures"
        ],
        "studyDesignCriteria": [
          "Randomized",
          "Blinded",
          "Phase 2",
          "Phase 3"
        ],
        "specialPopulationCriteria": [
          "Renal insufficiency",
          "Elderly populations",
          "Device-related conditions",
          "Patients with LVADs"
        ]
      },
      "autoimmune": {
        "primaryClassificationFields": {
          "diseaseCategory": [
            "Rheumatoid Arthritis",
            "Systemic Lupus Erythematosus",
            "Multiple Sclerosis",
            "IBD",
            "Psoriasis"
          ],
          "diseaseActivityScores": ["DAS28", "SLEDAI", "EDSS", "Mayo Score", "PASI"],
          "biomarkers": ["Auto-antibodies", "Inflammatory markers", "Specific disease markers"],
          "priorTreatments": ["Conventional DMARDs", "Biologics", "Steroids"]
        },
        "primaryEndpoints": [
          "Disease activity scores",
          "Remission rates",
          "Radiographic progression",
          "Quality of life measures",
          "Steroid-free remission"
        ],
        "studyDesignCriteria": [
          "Phase 1",
          "Phase 2",
          "Phase 3",
          "Blinded"
        ],
        "specialPopulationCriteria": ["Pediatric populations", "Severe disease activity"]
      },
      "infectiousDisease": {
        "primaryClassificationFields": {
          "pathogenType": ["Viral", "Bacterial", "Fungal", "Parasitic"],
          "infectionSite": [
            "Respiratory",
            "Bloodstream",
            "CNS",
            "Skin/Soft tissue",
            "GI tract",
            "Urinary tract"
          ],
          "resistanceProfile": ["Susceptible", "MDR", "XDR", "PDR"],
          "riskFactors": ["Immunocompromised", "Healthcare-associated", "Community-acquired"]
        },
        "primaryEndpoints": [
          "Clinical cure",
          "Microbiological eradication",
          "Time to resolution",
          "Mortality",
          "Recurrence rate",
          "Resistance development"
        ],
        "studyDesignCriteria": [
          "Phase 1",
          "Phase 2",
          "Phase 3",
          "Randomized",
          "Blinded"
        ],
        "specialPopulationCriteria": ["Neutropenic patients", "ICU patients"]
      }
    }
  }
  